Annual Cash & Cash Equivalents
$50.90 M
-$19.60 M-27.80%
December 31, 2023
Summary
- As of February 8, 2025, KALA annual cash & cash equivalents is $50.90 million, with the most recent change of -$19.60 million (-27.80%) on December 31, 2023.
- During the last 3 years, KALA annual cash & cash equivalents has fallen by -$26.37 million (-34.13%).
- KALA annual cash & cash equivalents is now -70.22% below its all-time high of $170.90 million, reached on December 31, 2018.
Performance
KALA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$49.20 M
-$5.00 M-9.22%
September 30, 2024
Summary
- As of February 8, 2025, KALA quarterly cash and cash equivalents is $49.20 million, with the most recent change of -$5.00 million (-9.22%) on September 30, 2024.
- Over the past year, KALA quarterly cash and cash equivalents has dropped by -$6.86 million (-12.24%).
- KALA quarterly cash and cash equivalents is now -74.96% below its all-time high of $196.46 million, reached on March 31, 2020.
Performance
KALA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KALA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.8% | -12.2% |
| 3 y3 years | -34.1% | -30.2% |
| 5 y5 years | -70.2% | -30.2% |
KALA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.8% | at low | -46.6% | +15.6% |
| 5 y | 5-year | -44.8% | at low | -75.0% | +15.6% |
| alltime | all time | -70.2% | +783.8% | -75.0% | +86.7% |
Kala Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $49.20 M(-9.2%) |
| Jun 2024 | - | $54.20 M(+11.8%) |
| Mar 2024 | - | $48.48 M(-4.7%) |
| Dec 2023 | $50.90 M(-27.8%) | $50.90 M(-9.2%) |
| Sep 2023 | - | $56.06 M(+13.8%) |
| Jun 2023 | - | $49.26 M(-22.6%) |
| Mar 2023 | - | $63.64 M(-9.7%) |
| Dec 2022 | $70.50 M(-23.5%) | $70.50 M(+34.6%) |
| Sep 2022 | - | $52.39 M(+23.1%) |
| Jun 2022 | - | $42.57 M(-34.7%) |
| Mar 2022 | - | $65.17 M(-29.3%) |
| Dec 2021 | $92.14 M(+19.2%) | $92.14 M(-26.0%) |
| Sep 2021 | - | $124.50 M(-13.9%) |
| Jun 2021 | - | $144.63 M(+13.0%) |
| Mar 2021 | - | $127.97 M(+65.6%) |
| Dec 2020 | $77.26 M | $77.26 M(+69.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $45.53 M(-64.4%) |
| Jun 2020 | - | $128.02 M(-34.8%) |
| Mar 2020 | - | $196.46 M(+129.9%) |
| Dec 2019 | $85.45 M(-50.0%) | $85.45 M(-12.4%) |
| Sep 2019 | - | $97.56 M(-17.3%) |
| Jun 2019 | - | $118.01 M(-15.1%) |
| Mar 2019 | - | $138.94 M(-18.7%) |
| Dec 2018 | $170.90 M(+49.2%) | $170.90 M(+128.1%) |
| Sep 2018 | - | $74.91 M(-17.9%) |
| Jun 2018 | - | $91.20 M(-9.3%) |
| Mar 2018 | - | $100.53 M(-12.3%) |
| Dec 2017 | $114.56 M(+151.9%) | $114.56 M(-6.1%) |
| Sep 2017 | - | $122.05 M(+363.2%) |
| Jun 2017 | - | $26.35 M(-26.9%) |
| Mar 2017 | - | $36.02 M(-20.8%) |
| Dec 2016 | $45.47 M(+689.6%) | $45.47 M |
| Dec 2015 | $5.76 M | - |
FAQ
- What is Kala Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Kala Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Kala Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of KALA is $50.90 M
What is the all time high annual cash & cash equivalents for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual cash & cash equivalents is $170.90 M
What is Kala Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, KALA annual cash & cash equivalents has changed by -$19.60 M (-27.80%)
What is Kala Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KALA is $49.20 M
What is the all time high quarterly cash and cash equivalents for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly cash and cash equivalents is $196.46 M
What is Kala Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, KALA quarterly cash and cash equivalents has changed by -$6.86 M (-12.24%)